Clinical Trials Browser

INDUSTRY × givinostat × Lymphoid × Clear all

NCT00496431 2022-01-27

phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients

Phase 1/2 Terminated

Hodgkin Disease

NCT00792467 2021-05-11

Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma

Phase 1/2 Completed

24 enrolled 13 charts

Hodgkin Disease